The secondary objective is to evaluate the effectiveness of an 8-week LLLT versus MET compared to CTE on pain intensity, shoulder ROM, interleukin 6 (IL-6), depression, anxiety, and QoL. This evidence concerns the gene IL6 and major depressive disorder.